Barely Significant
← all excerpts

MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer.

Cancers (Basel) · 2025 · PMC12691313 · PMID 41375002

Europe PMCDOI
2
hedged sentences
0.1450
closest p · 2.9× alpha
0.1450
boldest claim

The sentences

showed a trendp = 0.145not close (p > 0.1)
MET overexpression showed a trend toward improved PFS (HR: 0.77, 95% CI: 0.54–1.09, p = 0.145) ( Figure 3 A).

also in 53,322 other papers

did not reach statistical significanceno p-value reported
Other variables including PD-L1 expression, brain metastases, treatment regimen, and smoking status did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.